Eli Lilly to Acquire Three Vaccine Companies for Up to $38.3B

According to Eli Lilly's statement on May 26, the pharmaceutical company has agreed to acquire Curevo, LimmaTech Biologics, and Vaccine Company in an all-cash deal with a total value of up to $38.3 billion.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments